GnRH antagonist in IVF poor-responder patients: Results of a randomized trial

Reproductive BioMedicine Online

Volumn 11, Issue 2, 2005, Pages 189-193

  Marci, Roberto ^a   Caserta, Donatella ^a   Dolo, Vincenza ^a   Tatone, Carla ^a   Pavan, Antonio ^a   Moscarini, Massimo ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

GnRH antagonist; Ovarian stimulation; Poor responder; Treatment outcome

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LEUPRORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; AMPOULE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OVARY CYCLE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TRANSVAGINAL ECHOGRAPHY;

EID: 23144449759     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1472-6483(10)60957-1     Document Type: Article

References (35)

1. Albano C, Felberbaum RE, Smitz J et al. 2000 Controlled ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the LHRH-antagonist cetrorelix (Cetrotide) and the LHRH-agonist buserelin. Human Reproduction 15, 526-531.
2. Al-Inany H, Aboulghar M 2002 GnRH antagonist in assisted reproduction a Cochrane review. Human Reproduction 17, 874-885.
3. Akman MA, Erden HF, Tosun SB et al. 2000 Addition of GnRH antagonist in cycles of poor responders undergoing IVF. Human Reproduction 15, 2145-2147.
4. Akman MA, Erden HF, Tosun SB et al. 2001 Comparison of agonistic flare-up protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Human Reproduction 16, 868-870.
5. Ben Rafael Z, Orvieto R, Feldberg D 1994 The poor responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program. Gynecological Endocrinology 8, 277-286.
6. Broekmans FJ, Weima SM, te Velde ER 2003 A randomized comparison of two ovarian stimulation protocols with gonadotrophin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. Journal of Clinical Endocrinology and Metabolism 88, 4510.
7. Chang PL, Zeitoun KM, Chan L-K et al. 2002 GnRH antagonist in older IVF patients: retrieval rates and clinical outcome. Journal of Reproductive Medicine 47, 253-258.
8. Copperman AB 2003 Antagonist in poor responder patients. Fertility and Sterility 80 (Suppl. 1), S16.
9. Craft I, Gorgy A, Hill J et al. 1999 Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols? Human Reproduction 14, 2959-2962.
10. Crosignani PG, Ragni G, Lombroso GC et al. 1989 IVF: induction of ovulation in poor responders. Journal of Steroid and Biochemistry and Molecular Biology 32, 171-173.
11. de Jong D, Macklon NS, Eijkemans MJ et al. 2001 The dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotrophin-releasing hormone antagonist ganirelix (Orgalutran/Antagon). Fertility and Sterility 75, 688-693.
12. Diedrich K, Diedrich C, Santos E et al. 1994 Suppression of the endogenous luteinizing-hormone surge by the gonadotrophin-releasing hormone antagonist cetrorelix during ovarian stimulation. Human Reproduction 9, 788-791.
13. Fasouliotis SJ, Laufer N, Sabbagh-Ehrlich S et al. 2003 Gonadotrophin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF. Journal of Assisted Reproductive and Genetics 20, 455-460.
14. Feldberg D, Farhi J, Ashkenazi J et al. 1994 Minidose gonadotrophin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertility and Sterility 62, 343-346.
15. Frydman R, Cornel C, de Ziegler D et al. 1991 Prevention of premature luteinizing hormone and progesterone rise with a gonadotrophin-relasing hormone antagonist, Na1-Glu in controlled ovarian hyperstimulation. Fertility and Sterility 56, 923-927.
16. Fujii S, Sagara M, Kudo H et al. 1997 A prospective randomized comparison between long and discontinuous long protocols of gonadotrophins-releasing hormone agonist for in vitro fertilization. Fertility and Sterility 67, 1166-1168.
17. Ganirelix Dose-Finding Study Group 1998 A double-blind, randomized, dose-finding study to assess the efficacy of gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle-stimulating hormone (Puregon). Human Reproduction 13, 3023-3031.
18. Germond M, Senn A, Reymond O et al. 1990 Why lose an in vitro fertilization cycle when stimulation fails? Fertility and Sterility 53, 936-938.
19. Hoffmann G, Toner G, Mausher S et al. 1989 High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low responder patients for in vitro fertilization. Journal of In Vitro Fertility and Embryo Transfer 6, 285-289.
20. Leung PCK 1999 GnRH receptor and potential action in human ovary. Gynaecology Endocrinology 13, 10.
21. Kligman I, Rosenwaks Z 2001 Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders. Fertility and Sterility 76, 1185-1190.
22. Klipstein S, Reindollar RH, Regan MM et al. 2004 Initiation of the gonadotrophin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mm. Fertility and Sterility 81, 714-715.
23. Mansour RT, Aboulghar MA, Serour GI et al. 2003 The use of gonadotrophin-releasing hormone antagonist in a flexible protocol: a pilot study. Journal of Clinical Endocrinology and Metabolism 88, 4510; author reply 4510-4511.
24. Meldrum DR, Wisot A, Hamilton F et al. 1989 Routine pituitary suppression with leuprofide before ovarian stimulation for oocyte retrieval. Fertility and Sterility 51, 455-459.
25. Nikolettos N, Al-Hasani S, Felberbaum R et al. 2001 Gonadotrophin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders European Journal of Obstetrics and Gynecology and Reproductive Biology 97, 202-207.
26. Olivennes F, Righini C, Fanchin R et al. 1996 A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high FSH concentrations on day-3. Human Reproduction 11, 1169-1172.
27. Olivennes F, Cunha-Filho JS, Fanchin R et al. 2002 The use of GnRH antagonists in ovarian stimulation. Human Reproduction Update 8, 279-290.
28. Schoolcraft W, Schlenker T, Gee M et al. 1997 Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle stimulating hormone flare, growth hormone protocol. Fertility and Sterility 67, 93-97.
29. Scott RT, Navot D 1994 Enhancement of ovarian responsiveness with micro-dose of GnRH agonist during ovulation induction for in vitro fertilization. Fertility and Sterility 61, 880-885.
30. Senn A, Germond M, de Grandi P 1996 IVF or ICSI: a choice strategy in case of male-related infertility. CIC Edizioni Internazionali 1, 137-148.
31. Serafini P, Stone B, Kerin J et al. 1988 An alternate approach to controlled ovarian hyperstimulation in 'poor responders': pretreatment with a gonadotrophin-releasing hormone analog. Fertility and Sterility 49, 90-95.
32. Surrey ER, Schoolcraft WB 2000 Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertility and Sterility 73, 667-676.
33. Surrey ES, Bower J, Hill DM et al. 1998 Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertility and Sterility 69, 419-424.
34. Tarlatzis BC, Zepiridis L, Grimbizis G et al. 2003 Clinical management of low ovarian response to stimulation for IVF: a systematic review. Human Reproduction Update 9, 61-76.
35. Van Hooff, MH, Alberda AT, Huisman GJ et al. 1993 Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study. Human Reproduction 8, 369-373.